Contact this trialFirst, we need to learn more about you.
Thrombopoietin Receptor Agonist
Ianalumab + Eltrombopag for Low Platelet Count
Recruiting1 awardPhase 3
Lake Success, New York
This trial tests two doses of ianalumab to see if it can help people with ITP whose first treatment didn't work.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.